Showing results (71-80 of 432) with videos related to
Sort By:
Pageof 44
Psychopharmacology|June 19, 2004
Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disordersBryan L Roth, S Mohammad Hanizavareh, Andrew E BlumJournal of Medicinal Chemistry|April 28, 2012
Chemocentric informatics approach to drug discovery: identification and experimental validation of selective estrogen receptor modulators as ligands of 5-hydroxytryptamine-6 receptors and as potential cognition enhancersRima Hajjo, Vincent Setola, Bryan L Roth, et al.Current Opinion in Cell Biology|April 1, 2014
Tuning up the right signal: chemical and genetic approaches to study GPCR functionsPatrick M Giguere, Wesley K Kroeze, Bryan L RothDrug Discovery Today|November 5, 2013
DREADDs: novel tools for drug discovery and developmentHyeong-Min Lee, Patrick M Giguere, Bryan L RothCNS Drug Reviews|December 14, 2004
Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacologyMarilyn A Davies, Douglas J Sheffler, Bryan L RothNeuropharmacology|July 22, 2008
Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinasesJohn A Allen, Prem N Yadav, Bryan L RothJournal of Neurochemistry|November 19, 2021
Molecular insights into psychedelic drug actionSamuel T Slocum, Jeffrey F DiBerto, Bryan L RothCell Reports|August 17, 2022
Molecular insights into the regulation of constitutive activity by RNA editing of 5HT2C serotonin receptorsRyan H Gumpper, Jonathan F Fay, Bryan L RothBioorganic & Medicinal Chemistry Letters|January 24, 2007
Further studies on the binding of N1-substituted tryptamines at h5-HT6 receptorsAbner Nyandege, Renata Kolanos, Bryan L Roth, et al.Bioinformatics (Oxford, England)|December 31, 2013
HTS navigator: freely accessible cheminformatics software for analyzing high-throughput screening dataDenis Fourches, Maria F Sassano, Bryan L Roth, et al.Pageof 44